Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of bevacizumab and trifluridine combination given bi-weekly to reduce severe neutropenia in patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

    Recruiting

    3 1 1 1
    Spain
  • A Study Testing BNT329 Safety and Effectiveness in Patients With Advanced Solid Tumors That Express the CA19-9 Tumor Marker

    Recruiting

    2 1 1
    Germany Spain
  • Study of Pre-Operative Treatments with Sotorasib and Drug Combination for Patients with Resectable Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Italy
  • Study on Chemotherapy with Irinotecan, Folinic Acid, Fluorouracil, Oxaliplatin, and Floxuridine for Patients with Colorectal Cancer Spread to the Liver

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study of ELVN-002 with Trastuzumab and Chemotherapy for Patients with Advanced HER2+ Solid Tumors, Colorectal Cancer, and Breast Cancer

    Not recruiting

    1 1 1 1
    Belgium France Italy The Netherlands Spain
  • Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Germany
  • Study on the Effectiveness of FOLFOX and Panitumumab for Patients with Metastatic Colorectal Cancer Without RAS Mutation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium France
  • Study of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    2 1 1 1
    France Germany Italy Spain
  • Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Norway Slovakia Sweden